Solution
Cell dissociation reagent
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Menu
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Reduce resources needed for validation, improve process consistency and reduce costs due to contamination risk with our animal-free, recombinant TrypsiNNex®.
Webinar details October 23, 2025 As pharmaceutical formulations become more complex, manufacturers are under increasing pressure to deliver safe, stable products without introducing unfamiliar ingredients. Proven excipients like Benzalkonium Chloride (BKC) offer a dependable solution—providing strong antimicrobial control while supporting formulation stability and multi-dose shelf life. In this webinar, we
Webinar details Thursday, November 20, 2025 10am EST (NA) / 3pm GMT (UK) / 4pm CET · 60 min The production of cell and gene therapies requires strict adherence to regulatory standards that ensure patient safety and product consistency. However, sourcing high-performing, animal-free raw materials that meet these standards remains
Why optimizing insulin supplementation is crucial Stem cells represent one of the most powerful tools in modern biomedical science. Their unique ability to both self-renew and differentiate into specialized cell types makes them invaluable for research, disease modeling, and the development of regenerative therapies. Realizing this potential, however, requires more
Our team is present at CPhI Worldwide, October 28-30, 2025 in Frankfurt. Let’s connect. Contact us to book a meeting. You can also visit our partners’ stands to obtain information on our company and products: Actylis Stand # 8.0S90, zone Excipients Covering: Canada, Benelux, Scandinavia, Germany, France, UK, Ireland, Spain, and
Cell dissociation is just one step in your workflow, but it could be the one that determines whether a batch succeeds or fails. There is constant pressure in cell-based vaccine production to maintain consistency, prevent contamination, and meet strict regulatory demands – all under tight timelines.
Københavnsvej 216
4600 Køge,
Denmark
+45 5667 1000
[email protected]
CVR-no. 13246149
